Vera Therapeutics (VERA) Total Liabilities (2020 - 2026)
Vera Therapeutics' (VERA) quarterly Total Liabilities came in at $122.0 million in Q1 2026, up 62.36% YoY from $75.2 million in Q1 2025, and down 6.27% on a QoQ basis from $130.2 million in Q4 2025.
Vera Therapeutics (VERA) Total Liabilities (2020 - 2026) Analysis & Trends
Vera Therapeutics (VERA) has 7 years of Total Liabilities data on file, last reported at $122.0 million in Q1 2026.
- Quarterly Total Liabilities rose 62.36% year-over-year to $122.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $122.0 million (up 62.36% YoY) and the FY2025 annual result came in at $130.2 million, up 65.82% from the prior year.
- Total Liabilities eased to $122.0 million in Q1 2026, from $130.2 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $130.2 million in Q4 2025 to a low of $25.7 million in Q3 2022.
- A 5-year average of $71.8 million and a median of $69.4 million in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities jumped 448.95% — and 2024, when it increased 6.32%.
- Tracing VERA's Total Liabilities over 5 years: stood at $54.5 million in 2022, then jumped by 35.46% to $73.9 million in 2023, then advanced by 6.32% to $78.5 million in 2024, then soared by 65.82% to $130.2 million in 2025, then fell by 6.27% to $122.0 million in 2026.
- The last three Total Liabilities figures came in at $122.0 million (Q1 2026), $130.2 million (Q4 2025), and $118.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Vera Therapeutics | 2.28 Bn | 2.28 Bn | - | 125.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 125.23 Mn |
| Mar 31, 2026 | 122.04 Mn |
| Dec 31, 2025 | 130.21 Mn |
| Sep 30, 2025 | 118.62 Mn |
| Jun 30, 2025 | 110.25 Mn |
| Mar 31, 2025 | 75.17 Mn |
| Dec 31, 2024 | 78.53 Mn |
| Sep 30, 2024 | 79.50 Mn |
| Jun 30, 2024 | 69.42 Mn |
| Mar 31, 2024 | 65.81 Mn |
| Dec 31, 2023 | 73.86 Mn |
| Sep 30, 2023 | 51.91 Mn |
| Jun 30, 2023 | 54.66 Mn |
| Mar 31, 2023 | 51.90 Mn |
| Dec 31, 2022 | 54.53 Mn |
| Sep 30, 2022 | 25.65 Mn |
| Jun 30, 2022 | 27.28 Mn |
| Mar 31, 2022 | 30.55 Mn |
| Dec 31, 2021 | 14.16 Mn |
| Sep 30, 2021 | 5.69 Mn |